These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 2906610)

  • 1. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
    Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
    Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fentanyl isothiocyanate reveals the existence of physically associated mu- and delta-opioid receptors mediating inhibition of adenylate cyclase in rat neostriatum.
    Schoffelmeer AN; Rice KC; Heijna MH; Hogenboom F; Mulder AH
    Eur J Pharmacol; 1988 Apr; 149(1-2):179-82. PubMed ID: 2840299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
    Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
    Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
    Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective effects of [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 and [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 (O-t-butyl), two new enkephalin analogues, on neurotransmitter release and adenylate cyclase in rat brain slices.
    De Vries TJ; Schoffelmeer AN; Delay-Goyet P; Roques BP; Mulder AH
    Eur J Pharmacol; 1989 Nov; 170(3):137-43. PubMed ID: 2575993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
    Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
    Schoffelmeer AN; De Vries TJ; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1993 Oct; 267(1):205-10. PubMed ID: 8229747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.
    De Vries TJ; Hogenboom F; Mulder AH; Schoffelmeer AN
    Brain Res Dev Brain Res; 1990 Jun; 54(1):63-9. PubMed ID: 2163782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
    Schoffelmeer AN; De Vries TJ; Hogenboom F; Hruby VJ; Portoghese PS; Mulder AH
    J Pharmacol Exp Ther; 1992 Oct; 263(1):20-4. PubMed ID: 1328606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonist activity of the cyclic somatostatin analogue CTP at mu- but not delta- and kappa-opioid receptors involved in presynaptic inhibition of neurotransmitter release.
    Mulder AH; Wardeh G; Kazmierski W; Hruby VJ
    Eur J Pharmacol; 1988 Nov; 157(1):109-14. PubMed ID: 2906879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic somatostatin analogues as potent antagonists at mu-, but not delta- and kappa-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain.
    Mulder AH; Wardeh G; Hogenboom F; Kazmierski W; Hruby VJ; Schoffelmeer AN
    Eur J Pharmacol; 1991 Nov; 205(1):1-6. PubMed ID: 1687463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of D-2 dopamine receptors strongly enhances the potency of enkephalins to inhibit dopamine-sensitive adenylate cyclase in rat neostriatum: involvement of delta- and mu-opioid receptors.
    Schoffelmeer AN; Hansen HA; Stoof JC; Mulder AH
    J Neurosci; 1986 Aug; 6(8):2235-9. PubMed ID: 3018189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of opioid receptor types modulating acetylcholine release in septal regions of the rat brain.
    Gazyakan E; Hennegriff M; Haaf A; Landwehrmeyer GB; Feuerstein TJ; Jackisch R
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jul; 362(1):32-40. PubMed ID: 10935530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of dopamine-stimulated cyclic AMP efflux from rat neostriatal slices by activation of mu- and delta-opioid receptors: a permissive role for D-2 dopamine receptors.
    Schoffelmeer AN; Hansen HA; Stoof JC; Mulder AH
    Eur J Pharmacol; 1985 Dec; 118(3):363-6. PubMed ID: 2417870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid-receptor-mediated inhibition of [3H]dopamine but not [3H]noradrenaline release from rat mediobasal hypothalamus slices.
    Heijna MH; Padt M; Hogenboom F; Schoffelmeer AN; Mulder AH
    Neuroendocrinology; 1991 Aug; 54(2):118-26. PubMed ID: 1662785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenoceptor-sensitive adenylate cyclase is inhibited by activation of mu-opioid receptors in rat striatal neurons.
    Van Vliet BJ; Ruuls SR; Drukarch B; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1991 Mar; 195(2):295-300. PubMed ID: 1651867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors.
    Schoffelmeer AN; Warden G; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1991 Jul; 258(1):237-42. PubMed ID: 1677039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.